David N. Hanna

David N. Hanna

Auto-generated profile, based on publicly available information

David N. Hanna

Vanderbilt University Medical Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Gastroenterology
Verified
Journal Article
Closed access
DHDavid N. Hanna
David N. Hanna
PSPaula Marincola Smith
Paula Marincola Smith
SNSergey V. Novitskiy
Sergey V. Novitskiy
MWM. Kay Washington
M. Kay Washington
JZJinghuan Zi
Jinghuan Zi
AMAnna L. Means
Anna L. Means

3 November 2021 in The American Surgeon™
Verified
Journal Article
Closed access
PDF file
DHDavid N. Hanna
David N. Hanna
MGMuhammad O. Ghani
Muhammad O. Ghani
AHAndrew Hermina
Andrew Hermina
AMAlexander Mina
Alexander Mina
CBChristina E. Bailey
Christina E. Bailey
DMDeepa Magge
Deepa Magge
Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) among patients with peritoneal carcinomatosis (PC) depend largely on the extent of peritoneal disease. Since PC is not reliably evaluated with cross-sectional imaging, tumor burden is often evaluated with diagnostic laparoscopy (DLS). The aims of this study are to evaluate the safety of DLS in patients with peritoneal disease and determine if DLS delays time to CRS-HIPEC. We performed an institutional retrospective review of 145 patients who underwent CRS-HIPEC between 2013 and 2020. Patients were divided into 2 groups: those who underwent an electively scheduled DLS prior to CRS-HIPEC and those who did not. Intraoperative and postoperative complications associated with DLS were determined from the surgeon’s operative report. Time from diagnosis of PC to CRS-HIPEC was compared between the 2 groups. Of the 145 patients available for analysis, 47% (68) underwent DLS and 44% (64) did not. Of all the diagnostic laparoscopies performed, there was 1 (1.5%) intraoperative complication. The duration between diagnosis of peritoneal carcinomatosis and surgery was 4.9 months among patients who underwent DLS prior to CRS-HIPEC and 4.3 months among patients who did not (P = .79). In this retrospective analysis, diagnostic laparoscopy prior to CRS-HIPEC demonstrated a comparable rate of DLS-associated complications compared to other gastrointestinal malignancies and does not prolong time from diagnosis to CRS-HIPEC. Thus, in patients undergoing evaluation for CRS-HIPEC, diagnostic laparoscopy provides significant value in patient selection without incurring perioperative risk or delay in CRS-HIPEC.

9 November 2022 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
DHDavid N. Hanna
David N. Hanna
RMRebekah Macfie
Rebekah Macfie
MGMuhammad O. Ghani
Muhammad O. Ghani
AHAndrew Hermina
Andrew Hermina
AMAlexander Mina
Alexander Mina
KIKamran Idrees
Kamran Idrees

21 December 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
DHDavid N. Hanna
David N. Hanna
RMRebekah Macfie
Rebekah Macfie
MGMuhammad O. Ghani
Muhammad O. Ghani
AHAndrew Hermina
Andrew Hermina
AMAlexander Mina
Alexander Mina
DMDeepa Magge
Deepa Magge

7 October 2022 in Surgery
Verified
Journal Article
Closed access
HLHeather A. Lillemoe
Heather A. Lillemoe
DHDavid N. Hanna
David N. Hanna
NBNaira Baregamian
Naira Baregamian
CSCarmen C. Solórzano
Carmen C. Solórzano
KTKyla P. Terhune
Kyla P. Terhune
CKColleen M. Kiernan
Colleen M. Kiernan

26 March 2022 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
DHDavid N. Hanna
David N. Hanna
KMKatlyn G. McKay
Katlyn G. McKay
MGMuhammad O. Ghani
Muhammad O. Ghani
HCHernan Correa
Hernan Correa
IZIrving J. Zamora
Irving J. Zamora
Harold LovvornHarold Lovvorn
Harold Lovvorn